Regulatory UpdatesAug 23, 2026•1 min read

Omega Pharma Recalls Napralief 250mg Tablets Over Missing PIL Text

By the PharmaCountry team

Omega Pharma Ltd is recalling specific batches of Napralief 250mg gastro‑resistant tablets because sections of the patient information leaflet and carton labeling are missing.

Omega Pharma Ltd is recalling specific batches of Napralief 250mg gastro‑resistant tablets. The recall is due to missing text in Section 2 and Section 3 of the Patient Information Leaflet (PIL) and on the carton packaging for the affected packs.

Compiled by the PharmaCountry team · Source: MHRA

Topics:#recall #Patient Information Leaflet #Napralief #Omega Pharma #MHRA #pharmaceutical safety